Lifecore Biomedical Inc (LFCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 05/31
| 05-2023 | 02-2023 | 11-2022 | 08-2022 | 05-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -60,279 | -23,772 | -10,966 | N/A |
| Depreciation Amortization | N/A | 10,807 | 8,594 | 4,354 | N/A |
| Income taxes - deferred | N/A | 57 | -13 | -17 | N/A |
| Accounts receivable | N/A | 8,943 | 12,483 | 7,238 | N/A |
| Accounts payable and accrued liabilities | N/A | 11,330 | 11,709 | 581 | N/A |
| Other Working Capital | N/A | 12,584 | 11,844 | 6,869 | N/A |
| Other Operating Activity | 0 | 1,379 | -24,299 | -9,160 | 0 |
| Operating Cash Flow | $N/A | $-15,179 | $-3,454 | $-1,101 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -14,309 | -4,074 | -3,361 | N/A |
| Net Acquisitions | N/A | 15,666 | N/A | 3,135 | N/A |
| Investing Cash Flow | $N/A | $1,357 | $-4,074 | $-226 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | -24,000 | 8,000 | 4,000 | N/A |
| Debt Issued | N/A | 3,367 | N/A | N/A | N/A |
| Debt Repayment | N/A | -3,199 | -76 | -27 | N/A |
| Common Stock Issued | N/A | 4,822 | 5,000 | N/A | N/A |
| Other Financing Activity | 0 | 34,139 | -209 | -67 | 0 |
| Financing Cash Flow | $N/A | $15,129 | $12,715 | $3,906 | $N/A |
| Beginning Cash Position | N/A | 1,643 | 1,643 | 1,643 | N/A |
| End Cash Position | N/A | 2,950 | 6,830 | 4,222 | N/A |
| Net Cash Flow | $N/A | $1,307 | $5,187 | $2,579 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | -15,179 | -3,454 | -1,101 | N/A |
| Capital Expenditure | N/A | -14,309 | -4,074 | -3,361 | N/A |
| Free Cash Flow | 0 | -29,488 | -7,528 | -4,462 | 0 |